Hempstract, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HPST research report →
About the company
Operating across the United States, Hempstract, Inc. develops and supplies products centered around cannabidiol (CBD) and cannabigerol (CBG). Its catalog features CBD in isolate powder form, alongside various distillate oils.
- CEO
- Ronald M. Herzfeld
- IPO
- 2021
- Employees
- 2
- HQ
- Warden, WA, US
Price Chart
- Market Cap
- $25.55M
- P/E
- -5.63
- P/S
- 8.35
- P/B
- 1.81
- EV/EBITDA
- -4.05
- Div Yield
- 0.00%
- Gross Margin
- 77.12%
- Op Margin
- -233.60%
- Net Margin
- -265.93%
- ROE
- -42.17%
- ROIC
- -19.09%
- Revenue
- $0 · 0.00%
- Net Income
- $-777,071 · 66.66%
- EPS
- $-0.00 · 88.46%
- Op Income
- $-462,366
- FCF YoY
- -135.95%
- 52W High
- $0.04
- 52W Low
- $0.00
- 50D MA
- $0.02
- 200D MA
- $0.01
- Beta
- 1.79
- Avg Volume
- 32.62K
Get TickerSpark's AI analysis on HPST
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our HPST coverage
Recent articles, reports, and earnings notes.
No research on HPST yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HPST report →Similar companies
Peers in the same neighborhood.